CIK 0001867066 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Journey Medical Corp
Sign in to watch- Ticker
- DERM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 471879539
- Phone
- 480-434-6670
- Business address
- 9237 E VIA DE VENTURA BLVD., SUITE 105, SCOTTSDALE, AZ, 85258
- 4 Grant or award Director acquired 9,728 shares (grant or award)
- 4 Grant or award Director acquired 9,728 shares (grant or award)
- 4 Grant or award Director acquired 9,728 shares (grant or award)
- 4 Other disposition 10% owner disposed of 250,000 shares (other)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 10,000 shares at $3.04 ($30,400)
- 4 Open-market buy President & CEO bought 10,000 shares at $3.48 ($34,790)
- 4 Open-market buy Director bought 30,000 shares at $3.47 ($104,100)
- 4 Open-market buy Director bought 20,000 shares at $3.40 ($68,000)
- 4 Open-market sale Interim CFO sold 2,450 shares at $3.75 ($9,188)
- 4 Open-market sale Director sold 2,500 shares at an average $3.51 ($8,771)
- 4 Open-market sale Director sold 1,745 shares at $5.22 ($9,109)
- 4 Open-market buy Director bought 33,000 shares at $2.98 ($98,340)
- 4 Open-market buy Director bought 15,000 shares at $2.98 ($44,700)
- 4 Open-market buy Director bought 30,000 shares at $2.97 ($89,100)
- 4 Open-market buy President & CEO bought 26,044 shares at $2.52 ($65,631)
- 4 Open-market buy Director bought 100,000 shares at $2.23 ($223,000)
- 4 Grant or award Director acquired 27,472 shares (grant or award)
- 4 Grant or award Director acquired 27,472 shares (grant or award)
- 4 Grant or award Director acquired 27,472 shares (grant or award)
Page 3 of 5 · 88 filings